Get the Stockscreener App
9.59
6.16%
-0.63
Tyra Biosciences Inc stock is traded at $9.59, with a volume of 251.46K.
It is down -6.16% in the last 24 hours and down -4.00% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$10.22
Open:
$10.26
24h Volume:
251.46K
Relative Volume:
0.74
Market Cap:
$569.54M
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-5.9565
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
-10.46%
1M Performance:
-4.00%
6M Performance:
-36.99%
1Y Performance:
-45.97%
1-Day Range:
$9.56
$10.43
1-Week Range:
$9.56
$10.93
52-Week Range:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
9.59 | 569.54M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.99 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
508.86 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.71 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
540.71 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
254.09 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
When the Price of (TYRA) Talks, People Listen - news.stocktradersdaily.com
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
California State Teachers Retirement System Sells 2,366 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 10,426 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
RA Capital Boosts Stake in Tyra Biosciences (TYRA) to 22.4% | TYRA Stock News - GuruFocus
Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail
June Brings on Some Huge Insider Buying - 24/7 Wall St.
Kernaghan buying at Western Forest Products (WEF) - The Globe and Mail
Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews
Two Sigma Investments LP Has $643,000 Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Two Sigma Investments LP Grows Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Jane Street Group LLC Acquires Shares of 26,297 Skillz Inc. (NYSE:SKLZ) - Defense World
Schwab International Equity ETF (NYSEARCA:SCHF) Shares Sold by Squarepoint Ops LLC - Defense World
Zumiez Inc. (NASDAQ:ZUMZ) Shares Sold by Two Sigma Investments LP - Defense World
Squarepoint Ops LLC Invests $253,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Two Sigma Advisers LP Purchases 92,800 Shares of ThredUp Inc. (NASDAQ:TDUP) - Defense World
Two Sigma Advisers LP Takes $162,000 Position in Innovex International, Inc. (NYSE:INVX) - Defense World
Two Sigma Advisers LP Makes New $171,000 Investment in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Bank of America Corp DE Purchases 11,804 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Klondike Silver (CVE:KS) Trading Up 50% – What’s Next? - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Rating of “Buy” from Analysts - Defense World
Wishbone Gold (LON:WSBN) Trading 21.6% Higher – Should You Buy? - Defense World
AGM Group (NASDAQ:AGMH) Rating Increased to Hold at Wall Street Zen - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of “Buy” from Analysts - Defense World
BlackRock MuniYield Michigan Quality Fund, Inc. (NYSE:MIY) Short Interest Up 21.4% in May - Defense World
Motorcar Parts of America, Inc. (NASDAQ:MPAA) Shares Sold by Two Sigma Advisers LP - Defense World
Trend Tracker for (TYRA) - news.stocktradersdaily.com
PortfolioPlus S&P 500 ETF (NYSEARCA:PPLC) Shares Up 2.2% – What’s Next? - Defense World
BNP Paribas Financial Markets Purchases New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Deutsche Bank AG Acquires 6,466 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Millennium Management LLC Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Bioscience Holds 2025 Annual Stockholders Meeting - TipRanks
TYRA Stock: Upcoming Oppenheimer Meeting Announcement | TYRA Sto - GuruFocus
Bank of America Corp DE Sells 1,164,431 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) - Defense World
Trading (TYRA) With Integrated Risk Controls - news.stocktradersdaily.com
Northern Trust Corp Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Piper Sandler Begins Coverage on Tyra Biosciences (NASDAQ:TYRA) - Defense World
HC Wainwright Forecasts Higher Earnings for Tyra Biosciences - Defense World
What is HC Wainwright’s Forecast for TYRA FY2026 Earnings? - Defense World
Tyra Biosciences (TYRA) Receives Overweight Rating from Piper Sandler | TYRA Stock News - GuruFocus
Tyra Biosciences (TYRA): Analyst Bullish with Overweight Rating and $33 Target | TYRA Stock News - GuruFocus
Dimensional Fund Advisors LP Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
(TYRA) Trading Report - news.stocktradersdaily.com
Transcript : Tyra Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 05 - marketscreener.com
Top Green Energy Stocks Worth Watching – May 12th - Defense World
Tyra Biosciences Reports Increased R&D Investment in Q1 2025 - TipRanks
Tyra Biosciences to Participate at Upcoming Investor Conferences - Citizen Tribune
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Rating of “Buy” by Brokerages - Defense World
Wells Fargo & Company MN Grows Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
What Will Tyra Biosciences Inc (NASDAQ: TYRA) Be Like In 2025 - Stocksregister
Tyra Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):